Psychopharmacology in myasthenia gravis patients with focus on depression
Loading...
Date
2019-08
Journal Title
Journal ISSN
Volume Title
Publisher
Medip Academy
Abstract
Myasthenia gravis is an autoimmune disease with a potential to disrupt brain function and cause depression as a result of the disease itself or treatment side effect. Some biological and psychological mechanisms have been proposed for the correlations between myasthenia gravis and depression. Depression might present in patients myasthenia gravis, and it might complicate the course of the disease. Adequate treatment might not only improve the depression but might also impact the myasthenia gravis in general.
Description
Keywords
Contraindication, Depression, Myasthenia gravis, Psychopharmacology, Side effect, Treatment
Citation
Wardhana Ida Bagus Gede Wisnu, Wahyuni Anak Ayu Sri, Arimbawa Komang. Psychopharmacology in myasthenia gravis patients with focus on depression. International Journal of Research in Medical Sciences. 2019 Aug; 7(8): 3230-3234